JPRN-UMIN000039592
Recruiting
未知
Investigations of ocular side effects of topically applied 0.002% EYBELIS - Investigations of ocular side effects of topically applied 0.002% EYBELIS
Shohzankai Medical Foundation Miyake Eye Hospital0 sites80 target enrollmentMarch 7, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shohzankai Medical Foundation Miyake Eye Hospital
- Enrollment
- 80
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Pathologies associate with ocular inflammation such as diabetes mellitus
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurityJPRN-UMIN000025361ara Medical University20
Recruiting
Not Applicable
Clinical evaluation for the effects of intraocular tissue plasminogen activator administration in various eye diseasesVarious eye diseasesJPRN-UMIN000015726Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan50
Completed
Not Applicable
Ocular surface evaluation in ocular hypertension or inicial glaucoma patients treated with drops.Ocular hypertension or Open angle Glaucoma with no previous treatment.H40.0H40.1RBR-7mmp6kniversidade Federal de São Paulo
Completed
Phase 2
Comparison of effect of topical ophthalmic drop tacrolimus 1% versus topical ophthalmic drop dexamethasone 1% in the treatment of patients with shield ulcerIRCT2016110630746N1Vice chancellor for research, Zahedan University of Medical Sciences20
Completed
Not Applicable
Testing of safety and effectiveness of Under eye serum and anti aging under eye serumCTRI/2018/03/012305ITC Life Sciences Technology Centre72